Sandoz Group AG (SWX: SDZ)

Market Cap	15.41B
Revenue (ttm)	9.09B
Net Income (ttm)	-7.19M
Shares Out	429.72M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	13.95
Dividend	0.45 (1.25%)
Ex-Dividend Date	May 3, 2024

Volume	470,884
Open	35.40
Previous Close	35.86
Day's Range	35.04 - 35.79
52-Week Range	22.70 - 38.52
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 5, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1886
• Employees: 22,633
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SDZ

Financial Performance

In 2023, EMSN's revenue was 2.21 billion, a decrease of -10.59% compared to the previous year's 2.48 billion. Earnings were 457.58 million, a decrease of -14.01%.

Financial numbers in USD